National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting, 70874 [07-6031]
Download as PDF
<![CDATA[
70874
Federal Register / Vol. 72, No. 239 / Thursday, December 13, 2007 / Notices
Administration, 4040 North Central
Expressway, suite 900, Dallas, TX
75204, 214–253–4952, FAX: 214–253–
4970, e-mail: david.arvelo@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the
Federal Register of October 11, 2007 (72
FR 57951), FDA announced that a
public workshop entitled ‘‘Quality
System Regulation Educational Forum
on Design Controls’’ would be held on
Friday, April 4, 2008. On page 57951, in
the second column, the Location portion
of the document is amended to read as
follows:
Location: The public workshop will
be held at the Adam’s Mark Hotel
Dallas, 400 North Olive St., Dallas, TX
75201, 214–922–8000. Directions to the
facility and additional information are
available at the FDA Medical Device
Industry Coalition Web site at https://
www.fmdic.org/.
Dated: December 7, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–24144 Filed 12–12–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
mstockstill on PROD1PC66 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Operations
and Technical Support at the NCI-Frederick.
Date: January 7, 2008.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Gaithersburg Hilton, 620 Perry
Parkway, Gaithersburg, MD 20877.
Contact Person: Lalita D. Palekar, PhD.
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
VerDate Aug<31>2005
17:10 Dec 12, 2007
Jkt 214001
Institute, 6116 Executive Blvd., Bethesda,
MD 20892–7405, 301–496–7575,
palekarl@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
G–Education.
Date: February 12–13, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Washington Silver
Spring, 8777 Georgia Ave., Silver Spring, MD
20910.
Contact Person: Sonya Roberson, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8109,
Bethesda, MD 20892, 301–594–1182,
robersos@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, R25(E)
Special Emphasis Panel (SEP).
Date: February 12, 2008.
Time: 5 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Washington Silver
Spring, 8777 Georgia Ave., Silver Spring, MD
20910.
Contact Person: Lynn M. Amende, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard Room
8105 Bethesda, MD 20892–8328, 301–451–
4759, amendel@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research, 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 4, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–6034 Filed 12–12–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Council for
Biomedical Imaging and Bioengineering.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Biomedical Imaging and
Bioengineering, NACBIB January 2008.
Date: January 25, 2008.
Open: 8:30 a.m. to 1 p.m.
Agenda: Report from the Institute Director
and other Institute staff and presentations of
working group reports.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Closed: 1 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Anthony Demsey, PhD,
Director, National Institute of Biomedical
Imaging and Bioengineering, 6701
Democracy Blvd., Room 241, Bethesda, MD
20892.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nibib1.nih.gov/about/NACBIB/
NACBIB.htm, where an agenda and any
additional information for the meeting will
be posted when available.
Dated: December 5, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–6031 Filed 12–12–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute On Aging; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\13DEN1.SGM
13DEN1
]]>Agencies
[Federal Register Volume 72, Number 239 (Thursday, December 13, 2007)]
[Notices]
[Page 70874]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-6031]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Advisory Council for Biomedical Imaging and
Bioengineering.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Biomedical
Imaging and Bioengineering, NACBIB January 2008.
Date: January 25, 2008.
Open: 8:30 a.m. to 1 p.m.
Agenda: Report from the Institute Director and other Institute
staff and presentations of working group reports.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Closed: 1 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Anthony Demsey, PhD, Director, National
Institute of Biomedical Imaging and Bioengineering, 6701 Democracy
Blvd., Room 241, Bethesda, MD 20892.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.nibib1.nih.gov/about/NACBIB/NACBIB.htm, where an
agenda and any additional information for the meeting will be posted
when available.
Dated: December 5, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-6031 Filed 12-12-07; 8:45 am]
BILLING CODE 4140-01-M
